Clinical trial
Intravitreal Aflibercept Injection as a Surgical Adjuvant in Severe Proliferative Diabetic Retinopathy
NCT01805297 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravitreal Aflibercept Injection as a Surgical Adjuvant in Severe Proliferative Diabetic Retinopathy
- Lead sponsor
- University of Oklahoma
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- November 30, 2015
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.